{"ticker": {"uuid": "0d53e69c-86d1-4491-8c34-cf8985bb995b", "symbol": "ODTX", "name": "Odyssey Therapeutics, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart | MEXC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1uX29QUEdjeElfdWNVeEM3UkFzT0VvdURnTVV0RU5aYS1Gb216emprU1Bta2haTkZQb3JoQmc2M2s4aTM0T0FkVDRfZ1drZw?oc=5", "source_name": "mexc.co", "published_at": "2026-07-21T18:59:06+00:00", "published_display": "21 Jul 2026 18:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price to sales forward of Odyssey Therapeutics, Inc. \u2013 NASDAQ:ODTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOREFkcVVCQlZZYzUwSVQwVFpZTVNMX1ZHcklGek5SR21vd0JGUVR2eElMclBfZF9YSFlSQmt1QWRQTkdFc0JSdHlLdkN6TVd1Wkpfajd4TU9SczZxNWp5MHo5RnlaT3Y4Y0ZaVmt0RTlrRk9DckZmd3hqRXhGWE53TXF6NFN0NjZDNW9VOXpzU1ZmNGdYR0hNa2FVSy0tdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T09:38:02+00:00", "published_display": "09 Jul 2026 09:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/odyssey-therapeutics-q1-earnings-snapshot-205147353.html", "source_name": "Associated Press", "published_at": "2026-06-17T20:51:47+00:00", "published_display": "17 Jun 2026 20:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/odyssey-therapeutics-reports-first-quarter-201500194.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T20:15:00+00:00", "published_display": "17 Jun 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Reports Positive Phase 2a Proof-of-Concept Data for OD-001 in Ulcerative Colitis and Q1 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxPN2c0X3kxODdibEo2ODA4aXBrRVA5WWc1YU5CbExSRnJ1enBqdDRaTGJmOEdWa0VyWHhHbHJYNWxQUXNxLWpNalVuVjJWbDBNTjZESFFoVVhkTTd4U3ZaUnZBQWIxN3BjYzNFaHN3MXN3LTk1cDRBSUdHb2VTcHZUdUpieGdWRHB3a0ZydWswNDVZb3dnRTgtaU1FM0NTVlNLTmRYaVhoemlqQzFZYnEtcGNEaTI5QjkyNS1MZFdxTnJIQTFaU3dJZk9kR29WaEhQWXkxY0hiOWlLRzVrZC1TMVZpQUZfYkZlOTZtaVVvUEpvU0diNnY0?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics (ODTX) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1Yd1hXc184SU9ibnU1ZVBua1R6V0pKX0lDWi1fbjE5VERReUNqVG5qMDlyVldmTk5ob3lwWnhsNXhqd1hNdXdRdWxuNHM0SGo3ZXdneWljM0pBc3ZTdmppbFN6anlJQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-16T20:04:28+00:00", "published_display": "16 May 2026 20:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimension Management Discloses Investment at Odyssey Therapeutics with 7.1% Stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQZUpQSkxzYUVRWlZid2EtZzNsWnZ4ZzNhUXlFbmZxSWhVejI4QnM2ODB4ZWdOY1dzMnc0NDVOR2ZxOWJuTlpxNnUxWTBYNm9RS0Y3a2JLQU5WSzlOTnlRMUVKS3R2Ull5SFluYVc3VWYyMGswdFRnWmdtN2Rtd0dlaDZ3Z3EtdVVLZWNtMzlVNzQxUE9XLW1jTGxOeVdhdEl3dzRJVld4Tlk1Qml4dkVQekJoZmR1TDdhOE5hYkttVUlpczIzdENoV2lhU3M3azRKUG8tT2VHNDRodw?oc=5", "source_name": "TradingView", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Odyssey Therapeutics (ODTX) Stock Chart and Price History 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5jS1Q4X3kyaWtpdHFMam94ZXBfYmJHcXhQRVB5M3BZWXpIbG1ubjhaX0pFbGxSWGVvRGc4MktTLVhibFFpSTJ2V05wbERLMTNiMlN3aXB6Ql9CcWtBOFE0T3BR?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-11T15:32:47+00:00", "published_display": "11 May 2026 15:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1pVVU3NmZXd25UUGcyME1BRGZEUVk4bGxSd1ludWV5X0JwZXhSS211RGltRDVDenVPbHZOd0lFbVBFRmVBZ2J1SzYydTZTRXQ4SWRkQ3hfbDBTUDloblhfQ044WDhxbnY3WmQ2cWlaZXJPNHB4R2c?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-11T15:32:44+00:00", "published_display": "11 May 2026 15:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics, Inc (ODTX) Stock Price Today: $17.25", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9jQzY0LUI5MHdrOC1rYUJnWklCMDJfRFc4UV8yWGQ0VHk2dVVvV2ZsY3czQm14OWlvaGk4NEhXU3FlVjhOX295cGhfU1hlbU1HSlVudTNzdw?oc=5", "source_name": "Gotrade", "published_at": "2026-05-11T14:45:59+00:00", "published_display": "11 May 2026 14:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare IPOs Raise $4.7 Billion As Odyssey, Mobia Debuts Slip", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/healthcare-ipos-raise-4-7-123114761.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T12:31:14+00:00", "published_display": "11 May 2026 12:31", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Raises $304M in Nasdaq IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNekhCSjJMd3pTZlJZRzNBWmd2amxJYkh3YnBTZEMzdS1QZENBQWxWMkQwZDFUaXJkZTZmNElWRTFhSE5BVWIwSnIxd0NvOHh5bUF2U3JMeUowZGUyNUhjai1oaGZHWGlLR1RZN3VQcl8xX1hBV3k0WW1jN1F5VTQ0bkw2dmIwSXNrY0tTVDRLR055RW5sY3NtczdRYkZlTFZtbzFHbA?oc=5", "source_name": "AllSci", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Odyssey Therapeutics (ODTX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9QX0YtNUhzMUJicWRWc0VpcEpPRTJ0UjBVeTJ2d0xDVmxBanJMOElMREtKQWpLRGJyUlFpU0czZzh3aldRQ0ZtRGM5R2sxcmpFZ0tBclNyN1UyQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-09T23:31:13+00:00", "published_display": "09 May 2026 23:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Rings the Nasdaq Stock Market Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQZ3hQcW50b2RpdDBIa2VLTUduVFBSc09mbzFuLWNNRjJMSnBkU0dRX004a0dVajBEWWdSNkFrWkl3T01PTTcwQUdQb2lRWlphRGFjeXVmN2txOUFZeXRJNHFxZUZfZjQzRGE4YXE4NlBPZ1Z2bTB6WFRCazl5WDBqdjFtZHc5bFM5ZjRGOWdJbmVacE0?oc=5", "source_name": "Nasdaq", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey\u2019s IPO Brings In $304M for Quest to Develop Better Immunology Drugs", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNcDl1Q0xYU3JINS1LUk92anVZb0Y2Tm1PRXhiN0x3QXNUU1plYlpEY0xkNTd2QW81LWVYSVU3QV9mTXBMVFh6N0xPbXY5bVkxQkVnbXQ3MkxBUkZOVFBaNi1zWlRpQTlyMmlvRTdUWDB6X21jTmQ5WExuY2tiUXp6Znh4X2lCN0dkMEU2WHRONHgtSTkwNnM4SjkxeklxZ1RJbzFRT1EyUGFPakpYalRoZHhmMXpuQ012QzNWTA?oc=5", "source_name": "MedCity News", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immunology drug developer Odyssey prices IPO (ODTX:Pending)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOV25PbGw5azlZRHBkbWpGX1QtSWxUaE56WlU4b2F1RU5TZ28tX3lMVzNNZ1lWM3FtTEF4bThQRE1kdTNBSGFlX2Q0elNVQUhoNFpSRWg5QlZ4TXlPX0ZSTzFRNzB4REhMdGhjTDVDcjBGT005NEQxbHdkeHNCUUJ6TVd3aHJ3SFJEdXc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Announces Upsized Initial Public Offering Pricing at $18.00 Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPZHcwaWtMeWVKa3BNVGRkZHRQMnltejZ4YWUwZDUzNkJiV1U5eld6RVl2NTFLM0d1UDlkVzJrSWdDTjNNMkFqVWZ5alYxdnZYS1gyZkVOMTE5eElvak5SazFRcTA2dmg0ZWRwOXYtLVBQXy1IVUVWMWkwZjN3ZmktM1h2Y3VaYVkwaFM3YVJZbEd3VjBteXhvNjBaUk1ka0tvamo1R2Jabk8wazlGU2pTVXFtd002M01uRVdWaEdkZG9PNDQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health stocks Odyssey, Mobia slide on trading debuts", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQUXVIaW03REp3S3RxWXIzTUR6R0Z1MTVXQ2FPaWh1V0djRWVxcndrUVVJclNTU0s4XzBVQ2d6OWZuQzBPU0VyWXdmanRkNjAxQnVCYVFjcHdhQnBvekhBM3VoWjVNMHUydm9rOXJ4cFd6NFp6VFlFOUd1bTBGV2hhalRPdnBveURPeGFxWjFR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPV2RLcENSR1VkUHNJZnZ4ZTNfSlJ6YWdDR05aWldyTm43aS1mMjRoQUFlbFJ5bU1lRXh2SEZTNnZYN01MLUJNSUc3bVpBTkk0eVVYRk40d2c2NWVIZUJXaHFJaFMtcG9ZeXF5VHMzdzV4NXpTcHg5UEJpaHV2ZEtZcnA4c1RrVF9fdUVSN1diNHlsbzExVmVxVkV2TGxWbjJacER3eTNDckRVY2JaM0dENXpwNzQ0LVJzN0JRanZB?oc=5", "source_name": "Stocktwits", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/odyssey-therapeutics-announces-pricing-upsized-004400401.html", "source_name": "GlobeNewswire", "published_at": "2026-05-08T00:44:00+00:00", "published_display": "08 May 2026 00:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$304M biotech IPO sends Odyssey Therapeutics to Nasdaq May 8", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPWWJ5UnVaUEQ0aUxKZGRQbTdXU2MzOUFVV0RseEdoMFRVQzZDQmRNNkltclFEOVFxY0JIakxlQ28zS0Y4MXBka3diZEMtZFFxTWxoUUgtRUlZTy1GOGxJLWZ2MzZFU0w4QzRLZGpNYzQ3eVdxcnRZQkpmMXRaYTNYQ1p0ZkdsQ1A4cGVvZFJPbk0tMm9Md0tIVFRneEcwUlNnMjVnMS1PQVg4UmxvSTVYdExvY2RvNmdJTFUw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFAxeHo3U0cxaWxuREZUa1RqdWtCci05VjcybDdrcGl3U1NlTk56dWQ1S1BHZmhSRUgtNzRycTVDMlQ0eF9McHNUUF85aHBlR1dI?oc=5", "source_name": "CNN", "published_at": "2026-05-05T20:58:06+00:00", "published_display": "05 May 2026 20:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech firm Odyssey targets $810 million valuation in US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPZWxqODB6eVRUWUg2NnZLbEhhZllOYlhTNWJVSTQwT2lMazZFX0xuY0lTMjlaVnI4NjU5bFlESnZTaVU2U01YQ1VpTExWbGVtOF9XUGZvWU1VZHVnNGZhUHBjXzNDOFQ2V1NZQVRQSnh3NTEwUnAyMG8zWmtETGx1RVRVc1Vod2pzSUFBdkY2UnFRMy1lb2VfREd5RlN3NllIeDZkVUd6WVdNQ3Fub0JDX0dja0NyYVJSckM3LUxMQ1JaT2R6VzFXNg?oc=5", "source_name": "Reuters", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Immunology drug developer Odyssey seeks U.S. IPO again", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOeDhBdzRqNmVDUWZ4MkVNSlZJeG1UTXVZc1VkeEFwNHZEakprVVlubl9Wa3VlZy1xbER0NWpKYjF1UFR3Y1ByRWt1Y05VaUwxR2RWTG1ublRUSUhfSTAxaEVpQ2h6ZGpZd3VYblA5YlJ2alhjZUtTUVc4NEhYSlY0dUxFU1ViWERVTklHLQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SANA Stock Price and Chart \u2014 NASDAQ:SANA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE13R05oa3B3b3FtTTI2RFhFRTBKTllmSTY3bDNNS3Y2QmZyOGpfRU9NT01GQ1NJT3ZubUZrMzk0VVBENzV1WDFwVVBNUlgtcFhjd1EwaERCa2lQQmdK?oc=5", "source_name": "TradingView", "published_at": "2021-02-03T17:53:33+00:00", "published_display": "03 Feb 2021 17:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart | MEXC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1uX29QUEdjeElfdWNVeEM3UkFzT0VvdURnTVV0RU5aYS1Gb216emprU1Bta2haTkZQb3JoQmc2M2s4aTM0T0FkVDRfZ1drZw?oc=5", "source_name": "mexc.co", "published_at": "2026-07-21T18:59:06+00:00", "published_display": "21 Jul 2026 18:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Odyssey Therapeutics, Inc. \u2013 NASDAQ:ODTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOREFkcVVCQlZZYzUwSVQwVFpZTVNMX1ZHcklGek5SR21vd0JGUVR2eElMclBfZF9YSFlSQmt1QWRQTkdFc0JSdHlLdkN6TVd1Wkpfajd4TU9SczZxNWp5MHo5RnlaT3Y4Y0ZaVmt0RTlrRk9DckZmd3hqRXhGWE53TXF6NFN0NjZDNW9VOXpzU1ZmNGdYR0hNa2FVSy0tdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T09:38:02+00:00", "published_display": "09 Jul 2026 09:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/odyssey-therapeutics-q1-earnings-snapshot-205147353.html", "source_name": "Associated Press", "published_at": "2026-06-17T20:51:47+00:00", "published_display": "17 Jun 2026 20:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/odyssey-therapeutics-reports-first-quarter-201500194.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T20:15:00+00:00", "published_display": "17 Jun 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Reports Positive Phase 2a Proof-of-Concept Data for OD-001 in Ulcerative Colitis and Q1 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxPN2c0X3kxODdibEo2ODA4aXBrRVA5WWc1YU5CbExSRnJ1enBqdDRaTGJmOEdWa0VyWHhHbHJYNWxQUXNxLWpNalVuVjJWbDBNTjZESFFoVVhkTTd4U3ZaUnZBQWIxN3BjYzNFaHN3MXN3LTk1cDRBSUdHb2VTcHZUdUpieGdWRHB3a0ZydWswNDVZb3dnRTgtaU1FM0NTVlNLTmRYaVhoemlqQzFZYnEtcGNEaTI5QjkyNS1MZFdxTnJIQTFaU3dJZk9kR29WaEhQWXkxY0hiOWlLRzVrZC1TMVZpQUZfYkZlOTZtaVVvUEpvU0diNnY0?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics (ODTX) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1Yd1hXc184SU9ibnU1ZVBua1R6V0pKX0lDWi1fbjE5VERReUNqVG5qMDlyVldmTk5ob3lwWnhsNXhqd1hNdXdRdWxuNHM0SGo3ZXdneWljM0pBc3ZTdmppbFN6anlJQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-16T20:04:28+00:00", "published_display": "16 May 2026 20:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimension Management Discloses Investment at Odyssey Therapeutics with 7.1% Stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQZUpQSkxzYUVRWlZid2EtZzNsWnZ4ZzNhUXlFbmZxSWhVejI4QnM2ODB4ZWdOY1dzMnc0NDVOR2ZxOWJuTlpxNnUxWTBYNm9RS0Y3a2JLQU5WSzlOTnlRMUVKS3R2Ull5SFluYVc3VWYyMGswdFRnWmdtN2Rtd0dlaDZ3Z3EtdVVLZWNtMzlVNzQxUE9XLW1jTGxOeVdhdEl3dzRJVld4Tlk1Qml4dkVQekJoZmR1TDdhOE5hYkttVUlpczIzdENoV2lhU3M3azRKUG8tT2VHNDRodw?oc=5", "source_name": "TradingView", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics (ODTX) Stock Chart and Price History 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5jS1Q4X3kyaWtpdHFMam94ZXBfYmJHcXhQRVB5M3BZWXpIbG1ubjhaX0pFbGxSWGVvRGc4MktTLVhibFFpSTJ2V05wbERLMTNiMlN3aXB6Ql9CcWtBOFE0T3BR?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-11T15:32:47+00:00", "published_display": "11 May 2026 15:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1pVVU3NmZXd25UUGcyME1BRGZEUVk4bGxSd1ludWV5X0JwZXhSS211RGltRDVDenVPbHZOd0lFbVBFRmVBZ2J1SzYydTZTRXQ4SWRkQ3hfbDBTUDloblhfQ044WDhxbnY3WmQ2cWlaZXJPNHB4R2c?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-11T15:32:44+00:00", "published_display": "11 May 2026 15:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics, Inc (ODTX) Stock Price Today: $17.25", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9jQzY0LUI5MHdrOC1rYUJnWklCMDJfRFc4UV8yWGQ0VHk2dVVvV2ZsY3czQm14OWlvaGk4NEhXU3FlVjhOX295cGhfU1hlbU1HSlVudTNzdw?oc=5", "source_name": "Gotrade", "published_at": "2026-05-11T14:45:59+00:00", "published_display": "11 May 2026 14:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare IPOs Raise $4.7 Billion As Odyssey, Mobia Debuts Slip", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/healthcare-ipos-raise-4-7-123114761.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T12:31:14+00:00", "published_display": "11 May 2026 12:31", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Raises $304M in Nasdaq IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNekhCSjJMd3pTZlJZRzNBWmd2amxJYkh3YnBTZEMzdS1QZENBQWxWMkQwZDFUaXJkZTZmNElWRTFhSE5BVWIwSnIxd0NvOHh5bUF2U3JMeUowZGUyNUhjai1oaGZHWGlLR1RZN3VQcl8xX1hBV3k0WW1jN1F5VTQ0bkw2dmIwSXNrY0tTVDRLR055RW5sY3NtczdRYkZlTFZtbzFHbA?oc=5", "source_name": "AllSci", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics (ODTX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9QX0YtNUhzMUJicWRWc0VpcEpPRTJ0UjBVeTJ2d0xDVmxBanJMOElMREtKQWpLRGJyUlFpU0czZzh3aldRQ0ZtRGM5R2sxcmpFZ0tBclNyN1UyQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-09T23:31:13+00:00", "published_display": "09 May 2026 23:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Rings the Nasdaq Stock Market Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQZ3hQcW50b2RpdDBIa2VLTUduVFBSc09mbzFuLWNNRjJMSnBkU0dRX004a0dVajBEWWdSNkFrWkl3T01PTTcwQUdQb2lRWlphRGFjeXVmN2txOUFZeXRJNHFxZUZfZjQzRGE4YXE4NlBPZ1Z2bTB6WFRCazl5WDBqdjFtZHc5bFM5ZjRGOWdJbmVacE0?oc=5", "source_name": "Nasdaq", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey\u2019s IPO Brings In $304M for Quest to Develop Better Immunology Drugs", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNcDl1Q0xYU3JINS1LUk92anVZb0Y2Tm1PRXhiN0x3QXNUU1plYlpEY0xkNTd2QW81LWVYSVU3QV9mTXBMVFh6N0xPbXY5bVkxQkVnbXQ3MkxBUkZOVFBaNi1zWlRpQTlyMmlvRTdUWDB6X21jTmQ5WExuY2tiUXp6Znh4X2lCN0dkMEU2WHRONHgtSTkwNnM4SjkxeklxZ1RJbzFRT1EyUGFPakpYalRoZHhmMXpuQ012QzNWTA?oc=5", "source_name": "MedCity News", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immunology drug developer Odyssey prices IPO (ODTX:Pending)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOV25PbGw5azlZRHBkbWpGX1QtSWxUaE56WlU4b2F1RU5TZ28tX3lMVzNNZ1lWM3FtTEF4bThQRE1kdTNBSGFlX2Q0elNVQUhoNFpSRWg5QlZ4TXlPX0ZSTzFRNzB4REhMdGhjTDVDcjBGT005NEQxbHdkeHNCUUJ6TVd3aHJ3SFJEdXc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Announces Upsized Initial Public Offering Pricing at $18.00 Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPZHcwaWtMeWVKa3BNVGRkZHRQMnltejZ4YWUwZDUzNkJiV1U5eld6RVl2NTFLM0d1UDlkVzJrSWdDTjNNMkFqVWZ5alYxdnZYS1gyZkVOMTE5eElvak5SazFRcTA2dmg0ZWRwOXYtLVBQXy1IVUVWMWkwZjN3ZmktM1h2Y3VaYVkwaFM3YVJZbEd3VjBteXhvNjBaUk1ka0tvamo1R2Jabk8wazlGU2pTVXFtd002M01uRVdWaEdkZG9PNDQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health stocks Odyssey, Mobia slide on trading debuts", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQUXVIaW03REp3S3RxWXIzTUR6R0Z1MTVXQ2FPaWh1V0djRWVxcndrUVVJclNTU0s4XzBVQ2d6OWZuQzBPU0VyWXdmanRkNjAxQnVCYVFjcHdhQnBvekhBM3VoWjVNMHUydm9rOXJ4cFd6NFp6VFlFOUd1bTBGV2hhalRPdnBveURPeGFxWjFR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPV2RLcENSR1VkUHNJZnZ4ZTNfSlJ6YWdDR05aWldyTm43aS1mMjRoQUFlbFJ5bU1lRXh2SEZTNnZYN01MLUJNSUc3bVpBTkk0eVVYRk40d2c2NWVIZUJXaHFJaFMtcG9ZeXF5VHMzdzV4NXpTcHg5UEJpaHV2ZEtZcnA4c1RrVF9fdUVSN1diNHlsbzExVmVxVkV2TGxWbjJacER3eTNDckRVY2JaM0dENXpwNzQ0LVJzN0JRanZB?oc=5", "source_name": "Stocktwits", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/odyssey-therapeutics-announces-pricing-upsized-004400401.html", "source_name": "GlobeNewswire", "published_at": "2026-05-08T00:44:00+00:00", "published_display": "08 May 2026 00:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$304M biotech IPO sends Odyssey Therapeutics to Nasdaq May 8", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPWWJ5UnVaUEQ0aUxKZGRQbTdXU2MzOUFVV0RseEdoMFRVQzZDQmRNNkltclFEOVFxY0JIakxlQ28zS0Y4MXBka3diZEMtZFFxTWxoUUgtRUlZTy1GOGxJLWZ2MzZFU0w4QzRLZGpNYzQ3eVdxcnRZQkpmMXRaYTNYQ1p0ZkdsQ1A4cGVvZFJPbk0tMm9Md0tIVFRneEcwUlNnMjVnMS1PQVg4UmxvSTVYdExvY2RvNmdJTFUw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFAxeHo3U0cxaWxuREZUa1RqdWtCci05VjcybDdrcGl3U1NlTk56dWQ1S1BHZmhSRUgtNzRycTVDMlQ0eF9McHNUUF85aHBlR1dI?oc=5", "source_name": "CNN", "published_at": "2026-05-05T20:58:06+00:00", "published_display": "05 May 2026 20:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech firm Odyssey targets $810 million valuation in US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPZWxqODB6eVRUWUg2NnZLbEhhZllOYlhTNWJVSTQwT2lMazZFX0xuY0lTMjlaVnI4NjU5bFlESnZTaVU2U01YQ1VpTExWbGVtOF9XUGZvWU1VZHVnNGZhUHBjXzNDOFQ2V1NZQVRQSnh3NTEwUnAyMG8zWmtETGx1RVRVc1Vod2pzSUFBdkY2UnFRMy1lb2VfREd5RlN3NllIeDZkVUd6WVdNQ3Fub0JDX0dja0NyYVJSckM3LUxMQ1JaT2R6VzFXNg?oc=5", "source_name": "Reuters", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immunology drug developer Odyssey seeks U.S. IPO again", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOeDhBdzRqNmVDUWZ4MkVNSlZJeG1UTXVZc1VkeEFwNHZEakprVVlubl9Wa3VlZy1xbER0NWpKYjF1UFR3Y1ByRWt1Y05VaUwxR2RWTG1ublRUSUhfSTAxaEVpQ2h6ZGpZd3VYblA5YlJ2alhjZUtTUVc4NEhYSlY0dUxFU1ViWERVTklHLQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SANA Stock Price and Chart \u2014 NASDAQ:SANA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE13R05oa3B3b3FtTTI2RFhFRTBKTllmSTY3bDNNS3Y2QmZyOGpfRU9NT01GQ1NJT3ZubUZrMzk0VVBENzV1WDFwVVBNUlgtcFhjd1EwaERCa2lQQmdK?oc=5", "source_name": "TradingView", "published_at": "2021-02-03T17:53:33+00:00", "published_display": "03 Feb 2021 17:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 67, "total_relevant": 47, "sentiment_summary": {"positive": 10, "negative": 3, "neutral": 34, "score": 53, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 16.05, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 9.5, "count": 18}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 17.61, "latest_week": "2026-07-17", "one_week_move": 5.5, "four_week_move": -7.7, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": 1.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 31.0044, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.5% over one week, -7.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "TradingView", "count": 5}, {"label": "MarketBeat", "count": 4}, {"label": "Seeking Alpha", "count": 3}, {"label": "GlobeNewswire", "count": 2}, {"label": "Quiver Quantitative", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Stocktwits", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 39}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 18}, {"label": "Guidance", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "39", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "7", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+5.5% over one week, -7.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart | MEXC"}], "updated_at": "2026-07-22T04:14:12.918786+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}